NCIt definition : A preparation of autologous T-lymphocytes that have been genetically modified to express
a chimeric antigen receptor (CAR) specific for the human tumor-associated antigen
(TAA) mesothelin (MSLN), with potential immunomodulating and antineoplastic activities.
Upon administration, the autologous anti-MSLN CAR-T cells UCLM802 specifically target
and kill MSLN-expressing tumor cells. Mesothelin, a cell surface glycoprotein involved
in cell adhesion, is overexpressed in a variety of cancer cell types.;